Spermicidal efficacy for STD prevention can be identified in six-month trials, cmte. told.
This article was originally published in The Tan Sheet
Executive Summary
SIX-MONTH SPERMICIDE TRIALS ARE ADEQUATE TO DEMONSTRATE EFFICACY OF STD PREVENTION, given the plethora of compliance problems associated with long-term efficacy studies, Lisa Kaiser, Alan Guttmacher Institute, recommended Nov. 20 at the joint FDA advisory committee meeting on spermicides in Gaithersburg, Md. Questioning the emphasis placed on long-term efficacy studies, Kaiser pointed to the difficulty and cost associated with such trials, which stems mainly from participants' reluctance to use spermicides for long periods of time.